
Mictura-DS Tablet
Marketer
AAR ESS Remedies Pvt Ltd
Salt Composition
Silodosin (8mg) + Dutasteride (0.5mg)
Overview Mictura-DS Tablet
Mictura-DS tablets combine two active ingredients with distinct mechanisms to manage benign prostatic hyperplasia (BPH) in adult males. This medication alleviates urinary symptoms such as frequent urination and hesitancy. It does not prevent prostate cancer. Consistent daily dosing is crucial; swallow the tablets whole—do not crush, chew, or break them. Dosage is determined by your physician. For optimal symptom management, maintain regular intake, even if feeling well. Symptom improvement may take up to four weeks; continue consistent use. Report any lack of improvement or symptom worsening after four weeks. Common side effects include reduced libido, erectile dysfunction, breast tenderness, and gynecomastia. Consult your doctor if these persist or are concerning. Dizziness and drowsiness are also possible, especially initially. The prescribed benefits outweigh the potential risks. This medication is not for use by women or children. Inform your doctor of any pre-existing conditions, including low blood pressure, liver or kidney disease, before commencing treatment, as suitability may be affected. Potential drug interactions exist; disclose all current medications. Condom use during sexual activity and regular blood pressure monitoring may be recommended. Discuss alcohol consumption with your healthcare provider.
Uses of Mictura-DS Tablet
Managing benign prostatic hyperplasia
Major Benefits of Mictura-DS Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mictura-DS Tablets. Ingest each tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Mictura-DS Tablet:
- Ejaculation disorder
- Impotence
- Decreased libido
- Breast enlargement in male
- Breast tenderness in male
- Headache
- Dizziness
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Nausea
- Abdominal pain
- Diarrhea
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Mictura-DS Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Mictura-DS Tablet with a meal.
How Mictura-DS Tablet works:
Mictura-DS tablets contain Silodosin and Dutasteride, a dual-action formulation addressing benign prostatic hyperplasia (BPH) symptoms. Silodosin, an alpha-adrenergic blocker, eases urination by relaxing bladder neck and prostate muscles. Dutasteride, a 5-alpha-reductase inhibitor, reduces prostate size by lowering levels of a growth-promoting hormone.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Mictura-DS tablets and alcohol may induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on Mictura-DS Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Mictura-DS Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Mictura-DS Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with kidney impairment should use Mictura-DS Tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Mictura-DS Tablets, as dose modification may be necessary. Consultation with a physician is advised. Mictura-DS Tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Mictura-DS Tablet :
Should you forget to take a Mictura-DS Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mictura-DS Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | The study of the urinary tract. |
